batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Patent invalidation restores the Daiichi status quo 18 January 2024 ASCO-GI – Jacobio’s KRAS looks competitive in pancreatic 17 January 2024 Ifinatamab goes pivotal 15 January 2024 FDA stops short of all-comers Keytruda label in cervical cancer 15 January 2024 Another Car-T scare might be hard to brush off 12 January 2024 Two more TIGIT setbacks 10 January 2024 ASCO-GU preview: showdown for Exelixis 10 January 2024 Blueprint clears the house in EGFR 9 January 2024 Load More